Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
4
MSBI Quote, Financials, Valuation and Earnings
Last price:
$17.25
Seasonality move
:
-2.5%
Day range:
$17.34 - $17.90
52-week range:
$17.34 - $28.08
Dividend yield:
7.03%
P/E ratio:
10.87x
P/S ratio:
1.30x
P/B ratio:
0.52x
Volume:
86.3K
Avg. volume:
103.6K
1-year change:
-28.93%
Market cap:
$379.2M
Revenue:
$299.7M
EPS (TTM):
-$1.05
Analysts' Opinion
-
Consensus RatingMidland States Bancorp has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $21.88, Midland States Bancorp has an estimated upside of 24.01% from its current price of $17.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.50 representing -16.21% downside risk from its current price of $17.64.
Fair Value
-
According to the consensus of 5 analysts, Midland States Bancorp has 24.01% upside to fair value with a price target of $21.88 per share.
MSBI vs. S&P 500
-
Over the past 5 trading days, Midland States Bancorp has underperformed the S&P 500 by -2.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Midland States Bancorp does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Midland States Bancorp revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Midland States Bancorp reported revenues of $75.6M.
Earnings Growth
-
Midland States Bancorp has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Midland States Bancorp reported earnings per share of -$2.52.
Enterprise value:
687.6M
EV / Invested capital:
0.59x
Price / LTM sales:
1.30x
EV / EBIT:
4.12x
EV / Revenue:
2.33x
PEG ratio (5yr expected):
--
EV / Free cash flow:
4.31x
Price / Operating cash flow:
3.41x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-0.17%
Net Income Margin (TTM):
-4.55%
Return On Equity:
-1.71%
Return On Invested Capital:
-1.03%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $322.5M | $298.4M | $295.3M | $77.5M | $75.6M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $4.24 | $2.96 | -$1.05 | $0.83 | -$2.52 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $2B | $1.4B | $1.5B | $506.2M | |
| Total Assets | $6.9B | $7.4B | $7.9B | $7.9B | $7.5B | |
| Current Liabilities | $69M | $170.7M | $222.5M | $295.3M | $87.5M | |
| Total Liabilities | $6.2B | $6.8B | $7.1B | $7.1B | $6.8B | |
| Total Equity | $621.4M | $663.8M | $758.6M | $791.9M | $736.1M | |
| Total Debt | $948.8M | $449.1M | $602.1M | $604.4M | $423.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $239.4M | $108.3M | $165.6M | $6.5M | $33.2M | |
| Cash From Investing | -$1.3B | -$341.8M | $142.8M | $42M | $11.1M | |
| Cash From Financing | $705.4M | $52.4M | -$318.6M | -$77.1M | -$47.1M | |
| Free Cash Flow | $236.5M | $99.8M | $159.7M | $4.1M | $31.1M | |
MSBI
Sector
Market Cap
$379.2M
$625.8M
Price % of 52-Week High
62.82%
86.55%
Dividend Yield
7.03%
1.95%
Shareholder Yield
14.62%
3.76%
1-Year Price Total Return
-28.93%
9.43%
Beta (5-Year)
0.714
0.712
Dividend yield:
7.03%
Annualized payout:
$1.24
Payout ratio:
-200.8%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$17.90
200-day SMA
Sell
Level
$22.69
Bollinger Bands (100)
Sell
Level
19.37 - 26.25
Chaikin Money Flow
Buy
Level
352.5K
20-day SMA
Sell
Level
$18.40
Relative Strength Index (RSI14)
Sell
Level
31.22
ADX Line
Sell
Level
29.3
Williams %R
Neutral
Level
-79.021
50-day SMA
Sell
Level
$19.85
MACD (12, 26)
Sell
Level
-0.62
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
3.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.462)
Sell
CA Score
(Annual)
Level (-2.1929)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.2351)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.
Stock Forecast FAQ
In the current month, MSBI has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The MSBI average analyst price target in the past 3 months is $21.88.
-
Where Will Midland States Bancorp Stock Be In 1 Year?
According to analysts, the consensus estimate is that Midland States Bancorp share price will rise to $21.88 per share over the next 12 months.
-
What Do Analysts Say About Midland States Bancorp?
Analysts are divided on their view about Midland States Bancorp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Midland States Bancorp is a Sell and believe this share price will drop from its current level to $20.50.
-
What Is Midland States Bancorp's Price Target?
The price target for Midland States Bancorp over the next 1-year time period is forecast to be $21.88 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MSBI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Midland States Bancorp is a Hold. 5 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MSBI?
You can purchase shares of Midland States Bancorp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Midland States Bancorp shares.
-
What Is The Midland States Bancorp Share Price Today?
Midland States Bancorp was last trading at $17.25 per share. This represents the most recent stock quote for Midland States Bancorp. Yesterday, Midland States Bancorp closed at $17.64 per share.
-
How To Buy Midland States Bancorp Stock Online?
In order to purchase Midland States Bancorp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 14.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.32% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is down 2.06% over the past day.
